The studies aim to increase understanding on immune responses to SARS-CoV-2

The novel STAR assay can rapidly determine telomere dysregulation in cancers and age-related diseases in clinical settings.

Since autumn 2019, the Fraunhofer Institute for Biomedical Engineering IBMT coordinates the BMBF-funded ERA-NET project “NExT” that aims […]

A new type of breast cancer drug can help halt progression of disease and is not toxic, according […]

Researchers are preparing to launch clinical trials of a drug used to cure a deadly disease caused by […]

A new study looked at how pharmacogenomics could improve the safety and effectiveness of COVID-19 drug therapies.

An extensive search and testing of current drugs and drug-like compounds has revealed compounds previously developed to fight […]

The interactive tool highlights unprecedented cross-sector collaboration

Idefirix is an immunosuppressant that reduces the level of donor specific antibodies, thus enabling transplantation

It is hoped that the vaccine will generate protection not only against SARS-CoV-2, but also against new strains […]